Navigation Links
Prix Galien USA Announces 2008 Final Candidates
Date:8/12/2008

Honorees for best pharmaceutical agent and best biotechnology product to be recognized at Sept. 24 gala ceremony

NEW YORK, Aug. 12 /PRNewswire-USNewswire/ -- The Prix Galien USA 2008 (http://www.prix-galien-usa.com) will recognize innovative biopharmaceutical drugs and devices that have made a deep impact on the quality of human life in ways that range from providing treatment for cancer and HIV/AIDS to hypertension and chronic pain. Charlie Rose will again emcee the awards ceremony on September 24, 2008, to be held at the American Museum of Natural History in New York.

The final candidates for the Prix Galien USA 2008 awards are:

-- Actelion Ltd. - Ventavis(R) (Iloprost)

-- Alexion Pharmaceuticals - Soliris(TM)

-- BioMarin Pharmaceutical Inc. - Nagalzyme(R)

-- Bristol-Myers Squibb - Sprycel(R)

-- Boehringer Ingelheim - Aptivus(R) and Spiriva(R)

-- Celgene Corporation - Revlimid(R)

-- CV Therapeutics Inc. - Ranexa(R) (ranolazine)

-- Elan Corporation - Prialt(R) (ziconotide intrathecal infusion)

-- Eli Lilly Company - Evista(R) raloxifene HCI

-- Genzyme Corporation - Myozyme(R)

-- GlaxoSmithKline - Tykerb(TM) (lapatinib) and Altabax(TM) (retapamulin ointment)

-- Merck & Co. - Isentress(R) (raltegravir)

-- Novartis AG - Exjade(R) (deferasirox) and Tekturna(R)

-- Nycomed - Omnaris

-- Pfizer Inc. - Selzentry(TM)

-- Roche Laboratories Inc. - Boniva(R)

-- sanofi-aventis - Lovenox(R)

-- Sanofi Pasteur - H5N1 influenza virus vaccine

-- Sucampo Pharmaceuticals, Inc. - Amitiza(R)

-- Wyeth - Infuse/InductOs (rh BMP-2 dibotermin alfa) Torisel (temsirolimus) Injection.

"Nominees for the Prix Galien USA stand apart from other drugs in the marketplace for the amount of research and level of skill that was invested to develop these innovative medicines that improve lives," said Gerald Weissmann, M.D., Prix Galien USA committee chair, New York University professor emeritus and editor-in-chief of The FASEB Journal.

At the awards ceremony The Population Council and Sheldon Segal, distinguished scientist at the organization, will receive the Prix Galien USA 2008 Pro Bono Humanum Award along with other members of the coalition -- Wyeth, Dow Corning and the late Judah Folkman of Harvard University -- that made possible the development and distribution of implantable hormone delivery systems that are used for birth control and family planning purposes by more than 8 million women worldwide.

The Prix Galien USA Awards (http://www.prix-galien-usa.com) committee of 11, including 7 Nobel Laureates, recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines that improve the human condition, and is considered the industry's highest accolade for pharmaceutical research and development -- equivalent to the Nobel Prize.


'/>"/>
SOURCE Prix Galien USA
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
2. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
3. Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment
4. Telik Announces Financial Results For 2008 Second Quarter
5. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
6. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
7. Genaera Corporation Announces Second Quarter Financial Results
8. China Biologic Products Announces Second Quarter 2008 Results Conference Call
9. Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
10. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
11. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Iowa (PRWEB) , ... October 12, 2017 , ... ... based in Vilnius, Lithuania, announced today that they have entered into a multiyear ... is to provide CRISPR researchers with additional tools for gene editing across all ...
(Date:10/12/2017)... Irvine, ca (PRWEB) , ... October 12, 2017 ... ... for the Surgical Wound Market with the addition of its newest module, US ... the $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first-ever genomics analysis platform specifically designed for life science researchers to analyze ... pioneering researcher Rosalind Franklin, who made a major contribution to the discovery ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
Breaking Biology Technology:
(Date:8/23/2017)... N.Y. , Aug. 23, 2017  The general public,s help is ... human microbiome—the bacteria that live in and on the human body –and ... The ... in the human microbiome, starting with the gut. The project's goal is ... disease. Photo credit: IBM ...
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at ... between startups and global businesses, taking place in ... startups will showcase the solutions they have built with IBM ... France is one of the most ... increase in the number of startups created between 2012 and ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
Breaking Biology News(10 mins):